1. Home
  2. KNRX vs DYAI Comparison

KNRX vs DYAI Comparison

Compare KNRX & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$0.86

Market Cap

27.4M

Sector

Technology

ML Signal

N/A

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.81

Market Cap

30.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
DYAI
Founded
2009
1979
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
30.8M
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
KNRX
DYAI
Price
$0.86
$0.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
4.8M
41.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,495,389.00
Revenue This Year
N/A
$12.52
Revenue Next Year
N/A
$92.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.58
52 Week Low
$0.76
$0.71
52 Week High
$3.45
$1.55

Technical Indicators

Market Signals
Indicator
KNRX
DYAI
Relative Strength Index (RSI) 43.10 43.46
Support Level $0.77 $0.71
Resistance Level $2.05 $0.98
Average True Range (ATR) 0.37 0.05
MACD -0.02 0.00
Stochastic Oscillator 5.11 35.32

Price Performance

Historical Comparison
KNRX
DYAI

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: